Keurig Green Mountain Gets Roasted
The pod has been dominating the coffee industry with introduction of the Keurig coffee machine, though the parent company is getting completely roasted. Keurig Green Mountain Inc (NASDAQ: GMCR) sunk nearly 30 percent in Thursday’s pre-market session.
The steep drop came in just after the speciality coffee-maker company reported disappointing quarterly results; EPS of $0.80 per share on sales of $969.6 million. Analysts were expecting earnings of $0.79 per share on revenues of $1.03 billion. Keurig reported reduced sales on both its coffee pods alongside its brewing systems.
Keurig also announced that it will cut 5 percent of its 6,600 employees (330 jobs) in order to reduce costs by ~$300 million in the next three years. The coffee specialist also reduced its earnings per share forecast for the fiscal year, specifying that it plans to spend ~$100 million on its cold-drink system. It mentioned the rising coffee prices, which will take a toll on sales of its coffee pods in the near future.
The company’s Kold system will allow consumers to make sports drinks, sodas, and other beverages with an easy click of a button, but it will be slightly more expensive than the usual Keurig system, at a price of $369.
Wall Street analysts had something to say about the coffee-maker:
- Morgan Stanley: Analyst Matthew Grainger downgraded the stock from Overweight to Equal-weight and slashed his price target from $110 down to $60. He pointed out the risk of erosion and feared the company’s ability for sustainable growth in earnings.
- Wedbush Securities: Reiterated at Neutral; reduced price target from $85 down to $67.
- Canaccord Genuity: Downgraded from Buy to Hold. Price target lowered from $120 to $65.
- Susquehanna Bank: Downgraded from Positive to Neutral.
SUMMARY: 3 Downgrades, 1 Reiterate; 2 Neutral, 1 Equal-weight, 1 Hold rating. Price target range from $60-$67.
The stock is down nearly 44 percent year-to-date.
Latest Ratings for GMCR
|Nov 2015||OTR Global||Downgrades||Mixed||Negative|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.